LAUREN HOLLIMAN: Open Payments
NPI 1215263652 · COLUMBUS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$136 in 7 payments from 4 companies in 2025. Trend: 2023 $174 · 2024 $95 · 2025 $136
Food & beverage: $136
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 4 | $80 |
| Amgen Inc. | 1 | $21 |
| Boston Scientific Corporation | 1 | $19 |
| Novo Nordisk Inc | 1 | $16 |
Products named: VERQUVO, Repatha, CDS - MCT/CEM Monitoring, Wegovy.
Industry payments across MS — which companies pay providers there.
